BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In Unit

Reuters2024-12-30

Dec 30 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:

DISPOSAL OF STAKE IN UNIT
MAXIMUM AMOUNT OF PURCHASE PRICE FOR DISPOSAL RMB98.2 MILLION
ESTIMATED THAT LOSS ON DISPOSAL MAY VARY BETWEEN RMB0.7 MILLION AND RMB27.4 MILLION

Further company coverage: 1541.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2495352913?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-30 23:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495352913","market":"us","top_or_hot":-1,"title":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In Unit","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In Unit</title></head><body><p><span>Dec 30 (Reuters)</span><span> - </span>ImmuneOnco Biopharmaceuticals Shanghai Inc <span>1541.HK</span>:</p><ul><li><p>DISPOSAL OF STAKE IN UNIT</p></li><li><p>MAXIMUM AMOUNT OF PURCHASE PRICE FOR DISPOSAL RMB98.2 MILLION</p></li><li><p>ESTIMATED THAT LOSS ON DISPOSAL MAY VARY BETWEEN RMB0.7 MILLION AND RMB27.4 MILLION</p></li></ul><p>Further company coverage: <span>1541.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-30 23:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NS0AT:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In UnitDec 30 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:DISPOSAL OF STAKE IN UNITMAXIMUM AMOUNT OF PURCHASE PRICE ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NS0AT:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01541","symbol_name":"宜明昂科-B","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NS0AT:1","article_id":"2495352913","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495352913","pubTimestamp":1735572296,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In UnitDec 30  - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:DISPOSAL OF STAKE IN UNITMAXIMUM AMOUNT OF PURCHASE PRICE FOR DISPOSAL RMB98.2 MILLIONESTIMATED THAT LOSS ON DISPOSAL MAY VARY BETWEEN RMB0.7 MILLION AND RMB27.4 MILLIONFurther company coverage: 1541.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01541":"宜明昂科-B","BK1161":"生物科技"},"translate_title":"简介-上海Immuneonco Biopharmaceuticals出售该部门的股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01541":0.9},"content_text":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In UnitDec 30 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:DISPOSAL OF STAKE IN UNITMAXIMUM AMOUNT OF PURCHASE PRICE FOR DISPOSAL RMB98.2 MILLIONESTIMATED THAT LOSS ON DISPOSAL MAY VARY BETWEEN RMB0.7 MILLION AND RMB27.4 MILLIONFurther company coverage: 1541.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2495352913"}